Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1672759Generated: November 1, 2026

Sodium Carbonate → HCID 86643696, compound

https://huagongshe.com/reaction/1672759

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium CarbonateHCID 10340—
ReactantPotassium AcetateHCID 517044—
Reactant2-Chloro-4-iodopyridineHCID 1516511—
ReactantBis(pinacolato)diboraneHCID 2733548—
ReactantHCID 67349728HCID 67349728—
CatalystHCID 178477754HCID 178477754—
Solvent1,4-DioxaneHCID 31275—
ProductHCID 86643696HCID 8664369643.1%

Reaction Conditions

Temperature100 °C

Reaction Steps

(S)-5-(3-Bromophenyl)-9-methylthio-1,2,3,3a,4,5-hexahydro-5,8,10,10b-tetraazabenzo[e]azulen-6-one (243 mg, 0.599 mmol) obtained in Step 1 of Example 13 was dissolved in 1,4-dioxane (7 mL), and the mixture was stirred at 100° C. for hours after adding bis(pinacolato)diboron (0.380 g, 1.50 mol), [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (PdCl2(dppf); 98.0 mg, 0.120 mmol), and potassium acetate (0.295 g, 3.00 mmol). The reaction mixture was filtered through sellite, and the filtrate was diluted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The residue obtained upon concentration under reduced pressure was then purified by silica gel column chromatography. The resulting crude product was dissolved in 1,4-dioxane/water=4/1 (12.5 mL), and the mixture was stirred at 100° C. for 3 hours after adding 2-chloro-4-iodopyridine (216 mg, 0.902 mmol), [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (PdCl2(dppf); 49.0 mg, 0.060 mmol), and sodium carbonate (191 mg, 1.80 mmol). The reaction mixture was then filtered through sellite, and the filtrate was extracted with ethyl acetate. The organic layer was then washed with saturated brine, and dried over anhydrous magnesium sulfate. The residue obtained upon concentration under reduced pressure was purified by silica gel column chromatography to give 5-[3-(2-chloropyridin-4-yl)phenyl]-9-methylthio-1,2,3,3a,4,5-hexahydro5,8,10,10b-tetraazabenzo[e]azulen-6-one (113 mg, 43% (2 steps)).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07998954B2
Source datasetuspto-grants-2011_08
ORD IDord-598b95ab8ad54ef0bdb2f7acd70e7619
Source noteuspto-grants-2011_08